Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.41 |
| ▸ | CSNK1D | P48730 | 4/20 | 0.38 |
| ▸ | CSNK1G2 | P78368 | 3/20 | 0.38 |
| ▸ | STS | P08842 | 1/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.34 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.34 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23625847 | 0.82 | STS (0.39) | STSPRMT5WDR77LIMK1 | |
| SCHEMBL23625848 | 0.81 | STS (0.42) | STSPRMT5WDR77LIMK1ALOX5AP | |
| SCHEMBL19735281 | 0.81 | CSNK1D (0.49) | KIF11CSNK1DCSNK1G2STSCSNK1A1 | |
| SCHEMBL23625530 | 0.80 | STS (0.41) | STSPRMT5WDR77LIMK1APP | |
| SCHEMBL24617017 | 0.78 | CSNK1D (0.49) | KIF11CSNK1DCSNK1G2CSNK1A1GSK3B | |
| SCHEMBL21692345 | 0.78 | PRMT5 (0.39) | STSPRMT5WDR77LIMK1SLC22A12 | |
| SCHEMBL26179243 | 0.76 | CSNK1D (0.34) | KIF11CSNK1DCSNK1G2 | |
| SCHEMBL21692241 | 0.76 | STS (0.40) | STSPRMT5WDR77LIMK1SLC22A12 | |
| SCHEMBL11633530 | 0.75 | CSNK1D (0.45) | KIF11CSNK1DCSNK1G2STSCSNK1A1 | |
| SCHEMBL21691644 | 0.75 | ALDH1A1 (0.37) | STSPRMT5WDR77LIMK1SLC22A12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | EXOC4, CYBA, SCO2 | KIF11 3243/4885CSNK1D 2537/4885CSNK1G2 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.